We aims to provide a complete knowledgeable report so that the readers will benefit from it. The report is properly examined and compiled by industry experts and will shed light on the key information that requires from the clients.
Case numbers are resurging in parts of the world where the COVID-19 pandemic was waning, falling in places that saw huge surges recently, and just beginning to rise in previously little-impacted parts of the globe.
Studying and analyzing the impact of Coronavirus COVID-19 on the Renal Diseases Drug industry, the report provide in-depth analysis and professtional advices on how to face the post COIVD-19 period.
Market Segment by Product Type
Chronic Kidney Disease (CKD) Drugs
End-Stage Kidney Disease (ESRD) Drugs
Market Segment by Product Application
Hospitals
Specialty Clinics
Other
Finally, the report provides detailed profile and data information analysis of leading company.
Pfizer
Amgen
Roche
GlaxoSmithKline (GSK)
Allergan
AbbVie
Kissei Pharmaceutical
AstraZeneca
FibroGen
Sanofi
Teva Pharmaceutical Industries
Johnson & Johnson
Keryx Biopharmaceuticals
Insights and Tools:
Projected and forecast revenue values are in constant U.S. dollars, unadjusted for inflation.
Product values and regional markets are estimated by market analyst, data analyst and people from related industry, based on companys' revenue and applications market respectively.
The data sources include but not limited to reports of companys,international organizations and governments, MMI market surveys,and related industry news.
Analyses of global market trends, with historical data, estimates for 2022 and projections of compound annual growth rates (CAGRs) through 2027
The market research includes historical and forecast data from like demand, application details, price trends, and company shares by geography, especially focuses on the key regions like United States, European Union, China, and other regions.
In addition, the report provides insight into main drivers,challenges,opportunities and risk of the market and strategies of suppliers. Key players are profiled as well with their market shares in the global market discussed.
Research Objectives
1.To study and analyze the global Renal Diseases Drug consumption (value) by key regions/countries, product type and application, history data from 2017 to 2021, and forecast to 2027.
2.To understand the structure of Renal Diseases Drug market by identifying its various subsegments.
3.Focuses on the key global Renal Diseases Drug manufacturers, to define, describe and analyze the value, market share, market competition landscape, Porter's five forces analysis, SWOT analysis and development plans in next few years.
4.To analyze the Renal Diseases Drug with respect to individual growth trends, future prospects, and their contribution to the total market.
5.To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
6.To project the consumption of Renal Diseases Drug submarkets, with respect to key regions (along with their respective key countries).
7.To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
8.To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
Global Renal Diseases Drug Market Research Report 2022, Forecast to 2027
1 Market Study Overview
1.1 Study Objectives
1.2 Renal Diseases Drug Introduce
1.3 Combined with the Analysis of Macroeconomic Indicators
1.4 Brief Description of Research methods
1.5 Market Breakdown and Data Triangulation
2 Global Trend Summary
2.1 Renal Diseases Drug Segment by Type
2.1.1 Chronic Kidney Disease (CKD) Drugs
2.1.2 End-Stage Kidney Disease (ESRD) Drugs
2.2 Market Analysis by Application
2.2.1 Hospitals
2.2.2 Specialty Clinics
2.2.3 Other
2.3 Global Renal Diseases Drug Market Comparison by Regions (2017-2027)
2.3.1 Global Renal Diseases Drug Market Size (2017-2027)
2.3.2 North America Renal Diseases Drug Status and Prospect (2017-2027)
2.3.3 Europe Renal Diseases Drug Status and Prospect (2017-2027)
2.3.4 China Renal Diseases Drug Status and Prospect (2017-2027)
2.3.5 Japan Renal Diseases Drug Status and Prospect (2017-2027)
2.3.6 Southeast Asia Renal Diseases Drug Status and Prospect (2017-2027)
2.4 Basic Product Information
2.4.1 Basic Product Information & Technology Development History
2.4.2 Product Manufacturing Process
2.4.3 Interview with Major Market Participants
2.4.4 High-end Market Analysis and Forecast
2.5 Coronavirus Disease 2019 (Covid-19): Renal Diseases Drug Industry Impact
2.5.1 Renal Diseases Drug Business Impact Assessment - Covid-19
2.5.2 Market Trends and Renal Diseases Drug Potential Opportunities in the COVID-19 Landscape
2.5.3 Measures / Proposal against Covid-19
3 Competition by Manufacturer
3.1 Global Renal Diseases Drug Sales and Market Share by Manufacturer (2017-2022)
3.2 Global Renal Diseases Drug Revenue and Market Share by Manufacturer (2017-2022)
3.3 Global Renal Diseases Drug Industry Concentration Ratio (CR5 and HHI)
3.4 Top 5 Renal Diseases Drug Manufacturer Market Share
3.5 Top 10 Renal Diseases Drug Manufacturer Market Share
3.6 Date of Key Manufacturers Enter into Renal Diseases Drug Market
3.7 Key Manufacturers Renal Diseases Drug Key Manufacturers
3.8 Mergers & Acquisitions Planning
4 Analysis of Renal Diseases Drug Industry Key Manufacturers
4.1 Pfizer
4.1.1 Compan Detail
4.1.2 Pfizer Renal Diseases Drug Product Introduction, Application and Specification
4.1.3 Pfizer 165 Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.1.4 Main Business Overview
4.1.5 Pfizer News
4.2 Amgen
4.2.1 Compan Detail
4.2.2 Amgen Renal Diseases Drug Product Introduction, Application and Specification
4.2.3 Amgen Renal Diseases Drug Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.2.4 Main Business Overview
4.2.5 Pfizer News
4.3 Roche
4.3.1 Compan Detail
4.3.2 Roche Renal Diseases Drug Product Introduction, Application and Specification
4.3.3 Roche Renal Diseases Drug Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.3.4 Main Business Overview
4.3.5 Roche News
4.4 GlaxoSmithKline (GSK)
4.4.1 Compan Detail
4.4.2 GlaxoSmithKline (GSK) Renal Diseases Drug Product Introduction, Application and Specification
4.4.3 GlaxoSmithKline (GSK) Renal Diseases Drug Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.4.4 Main Business Overview
4.4.5 GlaxoSmithKline (GSK) News
4.5 Allergan
4.5.1 Compan Detail
4.5.2 GlaxoSmithKline (GSK) Renal Diseases Drug Product Introduction, Application and Specification
4.5.3 Allergan Renal Diseases Drug Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.5.4 Main Business Overview
4.5.5 Allergan News
4.6 AbbVie
4.6.1 Compan Detail
4.6.2 AbbVie Renal Diseases Drug Product Introduction, Application and Specification
4.6.3 AbbVie Renal Diseases Drug Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.6.4 Main Business Overview
4.6.5 AbbVie News
4.7 Kissei Pharmaceutical
4.7.1 Compan Detail
4.7.2 Kissei Pharmaceutical Renal Diseases Drug Product Introduction, Application and Specification
4.7.3 Kissei Pharmaceutical Renal Diseases Drug Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.7.4 Main Business Overview
4.7.4 Main Business Overview
4.8 AstraZeneca
4.8.1 Compan Detail
4.8.2 AstraZeneca Renal Diseases Drug Product Introduction, Application and Specification
4.8.3 AstraZeneca Renal Diseases Drug Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.8.4 Main Business Overview
4.8.5 AstraZeneca News
4.9 FibroGen
4.9.1 Compan Detail
4.9.2 FibroGen Renal Diseases Drug Product Introduction, Application and Specification
4.9.3 FibroGen Renal Diseases Drug Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.9.4 Main Business Overview
4.9.5 FibroGen News
4.10 Sanofi
4.10.1 Compan Detail
4.10.2 Sanofi Renal Diseases Drug Product Introduction, Application and Specification
4.10.3 Sanofi Renal Diseases Drug Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.10.4 Main Business Overview
4.10.5 Sanofi News
4.11 Teva Pharmaceutical Industries
4.11.1 Compan Detail
4.11.2 Teva Pharmaceutical Industries Renal Diseases Drug Product Introduction, Application and Specification
4.11.3 Teva Pharmaceutical Industries Renal Diseases Drug Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.11.4 Main Business Overview
4.11.5 Teva Pharmaceutical Industries News
4.12 Johnson & Johnson
4.12.1 Compan Detail
4.12.2 Johnson & Johnson Renal Diseases Drug Product Introduction, Application and Specification
4.12.3 Johnson & Johnson Renal Diseases Drug Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.12.4 Main Business Overview
4.12.5 Johnson & Johnson News
4.13 Keryx Biopharmaceuticals
4.13.1 Company Details
4.13.2 Keryx Biopharmaceuticals Renal Diseases Drug Product Introduction, Application and Specification
4.13.3 Keryx Biopharmaceuticals Renal Diseases Drug Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.13.4 Main Business Overview
4.13.5 Keryx Biopharmaceuticals News
5 Global Renal Diseases Drug Market Segment by Big Type
5.1 Global Renal Diseases Drug Revenue, Sales and Market Share by Big Type (2017-2022)
5.1.1 Global Renal Diseases Drug Sales and Market Share by Big Type (2017-2022)
5.1.2 Global Renal Diseases Drug Revenue and Market Share by Big Type (2017-2022)
5.2 Chronic Kidney Disease (CKD) Drugs Sales Growth Rate and Price
5.2.1 Global Chronic Kidney Disease (CKD) Drugs Sales Growth Rate (2017-2022)
5.2.2 Global Chronic Kidney Disease (CKD) Drugs Price (2017-2022)
5.3 End-Stage Kidney Disease (ESRD) Drugs Sales Growth Rate and Price
5.3.1 Global End-Stage Kidney Disease (ESRD) Drugs Sales Growth Rate (2017-2022)
5.3.2 Global End-Stage Kidney Disease (ESRD) Drugs Price (2017-2022)
6 Global Renal Diseases Drug Market Segment by Big Application
6.1 Global Renal Diseases Drug Sales Market Share by Big Application (2017-2022)
6.2 Hospitals Sales Growth Rate (2017-2022)
6.3 Specialty Clinics Sales Growth Rate (2017-2022)
6.4 Other Sales Growth Rate (2017-2022)
7 Global Renal Diseases Drug Forecast
7.1 Global Renal Diseases Drug Revenue, Sales and Growth Rate (2022-2027)
7.2 Renal Diseases Drug Market Forecast by Regions (2022-2027)
7.2.1 North America Renal Diseases Drug Market Forecast (2022-2027)
7.2.2 Europe Renal Diseases Drug Market Forecast (2022-2027)
7.2.3 China Renal Diseases Drug Market Forecast (2022-2027)
7.2.4 Japan Renal Diseases Drug Market Forecast (2022-2027)
7.2.5 Southeast Asia Renal Diseases Drug Market Forecast (2022-2027)
7.2.6 Other Regions Renal Diseases Drug Market Forecast (2022-2027)
7.3 Renal Diseases Drug Market Forecast by Type (2022-2027)
7.3.1 Global Renal Diseases Drug Sales Forecast by Type (2022-2027)
7.3.2 Global Renal Diseases Drug Market Share Forecast by Type (2022-2027)
7.4 Renal Diseases Drug Market Forecast by Application (2022-2027)
7.4.1 Global Renal Diseases Drug Sales Forecast by Application (2022-2027)
7.4.2 Global Renal Diseases Drug Market Share Forecast by Application (2022-2027)
8 Market Analysis
8.1.1 Market Overview
8.1.2 Market Opportunities
8.1.3 Market Risk
8.1.4 Market Driving Force
8.1.5 Porter's Five Forces Analysis
8.1.6 SWOT Analysis
9 Renal Diseases Drug Related Market Analysis
9.1 Upstream Analysis
9.1.1 Macro Analysis of Upstream Markets
9.1.2 Key Players in Upstream Markets
9.1.3 Upstream Market Trend Analysis
9.1.4 Renal Diseases Drug Manufacturing Cost Analysis
9.2 Downstream Market Analysis
9.2.1 Macro Analysis of Down Markets
9.2.2 Key Players in Down Markets
9.2.3 Downstream Market Trend Analysis
9.2.4 Sales Channel, Distributors, Traders and Dealers
10 Research Findings and Conclusion
List of Tables and Figures
Figure Product Picture Renal Diseases Drug
Figure Market Concentration Ratio and Market Maturity Analysis of Renal Diseases Drug
Figure Bottom-up and Top-down Approaches for This Report
Figure Part of Our External Database
Figure Part of Our External Database
Figure Key Executives Interviewed
Table Global Renal Diseases Drug Market Size by Big Type
Figure Global Market Share of Renal Diseases Drug by Big Type in 2021
Figure Chronic Kidney Disease (CKD) Drugs Picture (2017-2022)
Global Renal Diseases Drug Market Size by Big Application
Table Global Renal Diseases Drug Market Size by Application
Figure Global Renal Diseases Drug Market Share by Big Application in 2021
Figure Hospitals Picture
Figure Specialty Clinics Picture
Figure Other Picture
Table Global Renal Diseases Drug Comparison by Regions (M USD) (2017-2027)
Figure Global Renal Diseases Drug Market Size (Million US$) (2017-2027)
Figure North America Renal Diseases Drug Revenue (Million US$) Growth Rate (2017-2027)
Figure Europe Renal Diseases Drug Revenue (Million US$) Growth Rate (2017-2027)
Figure China Renal Diseases Drug Revenue (Million US$) Growth Rate (2017-2027)
Figure Japan Renal Diseases Drug Revenue (Million US$) Growth Rate (2017-2027)
Figure Southeast Asia Renal Diseases Drug Revenue (Million US$) Growth Rate (2017-2027)
Table Business Impact Assessment - Covid-19
Table Market Trends and Renal Diseases Drug Potential Opportunities in the COVID-19 Landscape
Table Measures / Proposal against Covid-19
Table Global Renal Diseases Drug Sales by Manufacturer (2017-2022)
Figure Global Renal Diseases Drug Sales Market Share by Manufacturer in 2021
Table Global Renal Diseases Drug Revenue by Manufacturer (2017-2022)
Figure Global Renal Diseases Drug Revenue Market Share by Manufacturer in 2021
Table Global Renal Diseases Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Figure Top 5 Renal Diseases Drug Manufacturer (Revenue) Market Share in 2021
Figure Top 10 Renal Diseases Drug Manufacturer (Revenue) Market Share in 2021
Table Date of Key Manufacturers Enter into Renal Diseases Drug Market
Table Key Manufacturers Renal Diseases Drug Product Type
Table Mergers & Acquisitions Planning
Table Pfizer Company Profile
Table Renal Diseases Drug Product Introduction, Application and Specification of Pfizer
Table Renal Diseases Drug Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company One 2017-2022
Table Company One Main Business
Table Company One Recent Development
Table Amgen Company Profile
Table Renal Diseases Drug Product Introduction, Application and Specification of Amgen
Table Renal Diseases Drug Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Amgen Recent Development
Table Roche Company Profile
Table Renal Diseases Drug Product Introduction, Application and Specification of Roche
Table Renal Diseases Drug Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Roche Main Business
Table Roche Recent Development
Table GlaxoSmithKline (GSK) Company Profile
Table Renal Diseases Drug Product Introduction, Application and Specification of GlaxoSmithKline (GSK)
Table Renal Diseases Drug Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table GlaxoSmithKline (GSK) Main Business
Table GlaxoSmithKline (GSK) Recent Development
Table GlaxoSmithKline (GSK) Main Business
Table GlaxoSmithKline (GSK) Recent Development
Table Allergan Company Profile
Table Renal Diseases Drug Product Introduction, Application and Specification of Allergan
Table Renal Diseases Drug Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Allergan Main Business
Table Allergan Recent Development
Table AbbVie Company Profile
Table Renal Diseases Drug Product Introduction, Application and Specification of AbbVie
Table Renal Diseases Drug Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table AbbVie Main Business
Table AbbVie Recent Development
Table Kissei Pharmaceutical Company Profile
Table Renal Diseases Drug Product Introduction, Application and Specification of Kissei Pharmaceutical
Table Renal Diseases Drug Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Kissei Pharmaceutical Main Business
Table Kissei Pharmaceutical Recent Development
Table AstraZeneca Company Profile
Table Renal Diseases Drug Product Introduction, Application and Specification of AstraZeneca
Table Renal Diseases Drug Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table AstraZeneca Main Business
Table AstraZeneca Recent Development
Table FibroGen Company Profile
Table Renal Diseases Drug Product Introduction, Application and Specification of FibroGen
Table Renal Diseases Drug Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table FibroGen Main Business
Table FibroGen Recent Development
Table Sanofi Company Profile
Table Renal Diseases Drug Product Introduction, Application and Specification of Sanofi
Table Renal Diseases Drug Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Sanofi Main Business
Table Sanofi Recent Development
Table Teva Pharmaceutical Industries Company Profile
Table Renal Diseases Drug Product Introduction, Application and Specification of Teva Pharmaceutical Industries
Table Renal Diseases Drug Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Teva Pharmaceutical Industries Main Business
Table Teva Pharmaceutical Industries Recent Development
Table Johnson & Johnson Company Profile
Table Renal Diseases Drug Product Introduction, Application and Specification of Johnson & Johnson
Table Renal Diseases Drug Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Johnson & Johnson Main Business
Table Johnson & Johnson Recent Development
Table Keryx Biopharmaceuticals Company Profile
Table Renal Diseases Drug Product Introduction, Application and Specification of Keryx Biopharmaceuticals
Table Renal Diseases Drug Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Keryx Biopharmaceuticals Main Business
Table Keryx Biopharmaceuticals Recent Development
Figure Global Renal Diseases Drug Sales and Growth Rate (2017-2022)
Figure Global Renal Diseases Drug Revenue and Growth Rate (2017-2022)
Table Global Renal Diseases Drug Sales by Regions (2017-2022)
Figure Global Renal Diseases Drug Sales Market Share by Regions in 2021
Table Global Renal Diseases Drug Revenue by Regions (2017-2022)
Figure Global Renal Diseases Drug Revenue Market Share by Regions in 2021
Figure North America Renal Diseases Drug Sales and Growth Rate (2017-2022)
Figure Europe Renal Diseases Drug Sales and Growth Rate (2017-2022)
Figure China Renal Diseases Drug Sales and Growth Rate (2017-2022)
Figure Japan Renal Diseases Drug Sales and Growth Rate (2017-2022)
Figure Southeast Asia Renal Diseases Drug Sales and Growth Rate (2017-2022)
Figure Other Regions Renal Diseases Drug Sales and Growth Rate (2017-2022)
Table Global Renal Diseases Drug Sales by Big Type (2017-2022)
Table Global Renal Diseases Drug Sales Market Share by Big Type (2017-2022)
Figure Global Renal Diseases Drug Sales Market Share by Big Type in 2019
Table Global Renal Diseases Drug Revenue by Big Type (2017-2022)
Table Global Renal Diseases Drug Revenue Market Share by Big Type (2017-2022)
Table Global Renal Diseases Drug Revenue Market Share by Big Type in 2019
Figure Global Chronic Kidney Disease (CKD) Drugs Sales Growth Rate (2017-2022)
Figure Global Chronic Kidney Disease (CKD) Drugs Price (2017-2022)
Figure Global End-Stage Kidney Disease (ESRD) Drugs Sales Growth Rate (2017-2022)
Table Global Renal Diseases Drug Sales by Big Application (2017-2022)
Table Global Renal Diseases Drug Sales Market Share by Big Application (2017-2022)
Figure Global Renal Diseases Drug Sales Market Share by Big Application in 2019
Figure Global Hospitals Sales Growth Rate (2017-2022)
Figure Global Specialty Clinics Sales Growth Rate (2017-2022)
Figure Global Other Sales Growth Rate (2017-2022)
Figure Global Renal Diseases Drug Sales and Growth Rate (2022-2027)
Figure Global Renal Diseases Drug Revenue and Growth Rate (2022-2027)
Table Global Renal Diseases Drug Sales Forecast by Regions (2022-2027)
Table Global Renal Diseases Drug Market Share Forecast by Regions (2022-2027)
Figure North America Sales Renal Diseases Drug Market Forecast (2022-2027)
Figure Europe Sales Renal Diseases Drug Market Forecast (2022-2027)
Figure China Sales Renal Diseases Drug Market Forecast (2022-2027)
Figure Japan Sales Renal Diseases Drug Market Forecast (2022-2027)
Figure Southeast Asia Sales Renal Diseases Drug Market Forecast (2022-2027)
Figure Other Regions Sales Renal Diseases Drug Market Forecast (2022-2027)
Table Global Renal Diseases Drug Sales Forecast by Type (2022-2027)
Table Global Renal Diseases Drug Market Share Forecast by Type (2022-2027)
Table Global Renal Diseases Drug Sales Forecast by Application (2022-2027)
Table Global Renal Diseases Drug Market Share Forecast by Application (2022-2027)
Table Market Opportunities in Next Few Years
Table Market Risks Analysis
Table Market Drivers
Figure Porter's Five Forces Analysis
Table Macro Analysis of Upstream Markets
Table Key Players in Upstream Markets
Table Key Players of Upstream Markets
Table Key Raw Materials
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Renal Diseases Drug
Table Macro Analysis of Down Markets
Table Key Players in Down Markets
Table Key Players of Downstream Markets
Figure Sales Channel
Figure North America Renal Diseases Drug Sales (K Units) Growth Rate Forecast (2021-2025)
Figure North America Renal Diseases Drug Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure Europe Renal Diseases Drug Sales (K Units) Growth Rate Forecast (2021-2025)
Figure Europe Renal Diseases Drug Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure Japan Renal Diseases Drug Production (K Units) Growth Rate Forecast (2021-2025)
Figure Japan Renal Diseases Drug Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure China Renal Diseases Drug Production (K Units) Growth Rate Forecast (2021-2025)
Figure China Renal Diseases Drug Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure Methodology/Research Approach
Figure Market Size Estimation
Figure Author List
Pfizer
Amgen
Roche
GlaxoSmithKline (GSK)
Allergan
AbbVie
Kissei Pharmaceutical
AstraZeneca
FibroGen
Sanofi
Teva Pharmaceutical Industries
Global Freckle-removing Medical and Beau..
The global market for Freckle-removing Medical and Beauty Eq..
+16467917070US (Toll Free)